Maria Van Kerkhove is WHO Director of Epidemic and Pandemic Preparedness and Prevention, a role she assumed in 2024 after Sylvie Briand's retirement. She is the lead public voice on emerging outbreak risk including the MV Hondius Andes hantavirus cluster and the Bundibugyo ebolavirus PHEIC.

What did Maria Van Kerkhove say about the MV Hondius outbreak?

Van Kerkhove described the MV Hondius Andes hantavirus cluster as serious but not the next COVID, acknowledging person-to-person transmission potential while maintaining a low global-risk assessment in May 2026.Source: CIDRAP

How does Van Kerkhove's role differ from the WHO Director-General?

The Director-General, Tedros Adhanom Ghebreyesus, leads WHO overall. Van Kerkhove heads the specific programme responsible for epidemic and pandemic preparedness, giving her direct operational authority over outbreak risk assessments and technical guidance.

Background

Maria Van Kerkhove is a US-Born epidemiologist who serves as WHO Director of Epidemic and Pandemic Preparedness and Prevention, a role she assumed in 2024 following the retirement of Sylvie Briand. She joined WHO in 2017 and previously led the Emerging Diseases and Zoonosis unit, becoming publicly prominent during the COVID-19 pandemic as a technical lead for WHO's Health Emergencies Programme. She is known for calibrated public risk communication, consistently distinguishing between what is confirmed, what is plausible, and what remains unknown in fast-moving outbreak situations. Her academic background spans epidemiology and infectious disease, with field experience in MERS, Ebola, and influenza response before COVID.

Van Kerkhove publicly characterised the MV Hondius hantavirus cluster as "serious but not the next COVID" in May 2026, following confirmation of Andes virus in a Swiss disembarkee, the only hantavirus with documented person-to-person transmission capability. Her framing was load-bearing: it held the line between appropriate monitoring urgency and public alarm while acknowledging that Andes virus behaves differently from all other hantaviruses. WHO's Disease Outbreak News 599, published 2 May 2026, predated the Andes strain confirmation and carried a rodent-only risk framing that became outdated within days of publication. Van Kerkhove's position as the WHO's most visible communicator on the cluster made her assessment the reference point for national health agencies calibrating their response.

On the Bundibugyo PHEIC declared 17 May 2026, Van Kerkhove stated that WHO stood ready to deploy vaccines — but with the explicit caveat that their use depended on the species match: "should it turn out to be a strain where a vaccine can be used." The qualification matters: all approved Ebola vaccines and antibody therapies target Zaire ebolavirus only, with no licensed efficacy against Bundibugyo. Her framing signals WHO's awareness of the MCM gap without overpromising tools that do not exist — consistent with the calibrated communication style she applied throughout the Hondius cluster.

More questions

Who is Maria Van Kerkhove?

Maria Van Kerkhove is WHO Director of Epidemic and Pandemic Preparedness, a US-Born epidemiologist trained at Imperial College London who leads WHO's technical response to emerging infectious disease threats including H5N1 and COVID-19 variants.Source: https://www.who.int/director-general/dr-tedros-team/maria-van-kerkhove

What does the WHO Epidemic and Pandemic Preparedness directorate do?

The directorate led by Van Kerkhove coordinates WHO's surveillance, risk assessment, and member-state technical guidance on emerging outbreak threats, bridging the early detection phase and the formal Public Health Emergency of International Concern declaration process.Source: WHO official biography

What is WHO's current risk assessment for H5N1?

WHO, through Van Kerkhove's office, assesses the current H5N1 risk to the general public as low, while noting that the risk to people with occupational exposure to infected animals, particularly agricultural workers, remains higher and that surveillance must be intensified.Source: WHO H5N1 risk assessment communications, 2024-2025

Why did WHO appoint Van Kerkhove to lead pandemic preparedness?

Van Kerkhove was elevated to the pandemic preparedness directorship in 2024 on the basis of her central role managing WHO's technical COVID-19 response over four years, including chairing daily epidemiological briefings and coordinating the Emergency Use Listing process for vaccines.Source: WHO organisational announcements, 2024

How does WHO track emerging pandemic threats like H5N1?

WHO uses a combination of member-state notifications under the International Health Regulations, voluntary sequence submissions to GISAID, event-based surveillance via ProMED and GOARN, and Van Kerkhove's team's direct liaison with national public health authorities for real-time situational assessments.Source: WHO IHR and surveillance documentation

What did Maria Van Kerkhove say about the Bundibugyo Ebola outbreak?

Van Kerkhove stated WHO stood ready to deploy vaccines for Bundibugyo ebolavirus, but only 'should it turn out to be a strain where a vaccine can be used' — acknowledging that approved Ebola vaccines target Zaire ebolavirus only and have no licensed efficacy against Bundibugyo.Source: WHO

What did WHO say about the Hondius ship Andes virus outbreak?

Van Kerkhove characterised the MV Hondius Andes hantavirus cluster as 'serious but not the next COVID'. WHO's Disease Outbreak News 599 (2 May 2026) initially carried a rodent-only risk framing that was outdated within days when Andes virus — the only hantavirus capable of person-to-person transmission — was confirmed.Source: WHO

Is there a vaccine for Bundibugyo Ebola?

No. Approved vaccines (Ervebo) and antibody therapies (Inmazeb, Ebanga) target Zaire ebolavirus only. Van Kerkhove publicly flagged this constraint at the time of the 17 May 2026 PHEIC, stating vaccine deployment was conditional on the species match.Source: WHO / FDA

Source Material

WHO Health Emergencies Preparedness and Response Maria Van Kerkhove — Wikipedia WHO Health Emergency Preparedness team

How the World Sees Them

Global South

Health ministries in lower-income countries rely on Van Kerkhove's technical outputs to calibrate responses without the institutional capacity to conduct independent assessments of novel outbreak clusters.

United States

Van Kerkhove's dual American identity and WHO platform makes her a common target for US conservative commentators who dispute WHO pandemic governance, though her scientific credibility is broadly accepted across the public-health community.

European Union

EU health agencies treat Van Kerkhove's public statements as the authoritative WHO signal on emerging outbreak risk, and aligned their ECDC monitoring of the Hondius cluster with her risk framing.